BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 3, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2021
View Archived Issues
Oncolytic viruses target GSCs with specific p53 deregulations for personalized glioblastoma therapy
Read More
AMP-CpG-adjuvanted vaccine confers potent immunity against SARS-CoV-2 infection
Read More
CLEC4G and CD209 block SARS-CoV-2 entry into host cell
Read More
Shanghai Zheye Biotechnology patents G12C mutant GTPase KRAS inhibitors
Read More
New IL-17 modulators identified at UCB
Read More
ShanghaiTech University describes IKZF1/IKZF3 degradation inducers
Read More
BeiGene discovers non-receptor tyrosine-protein kinase TYK2 inhibitors
Read More
MIPS-521 exerts analgesic efficacy through stabilization of GPCR-G protein complex dynamics
Read More
Compound from a new class of antimalarials shows activity in vitro and in vivo
Read More
Immunic signs license agreement for DHODH inhibitors and nucleoside analogues for viral infections
Read More
Preclinical evaluation of novel mAChR subtype-selective M1 PAMs
Read More
NanoViricides reports preclinical data on NV-CoV-2-R
Read More
Characterization of potent and selective inhibitors of BET BD2
Read More
OncoNano expands research collaboration with UTSW on novel cancer therapeutics
Read More
BiVictriX completes two antibody discovery campaigns in support of BVX-001
Read More
Hexagon Bio raises funds to advance preclinical pipeline in oncology and infectious diseases
Read More
Rosalind Franklin University and Aptinyx collaborate on therapeutics for brain and CNS disorders
Read More
AbCellera and Everest Medicines collaborate to discover therapeutic antibodies
Read More
MDL-001 shown to protect mice against COVID-19-mediated weight loss
Read More
Seed funding at Opus Genetics supports progression of programs in Leber congenital amaurosis
Read More
VaxEquity collaborates with AstraZeneca to progress saRNA platform technology
Read More
Lymph dysfunction identified as potential metabolic target
Read More
Mydecine reports preclinical data supporting MYCO-003 for anxiety and PTSD
Read More
Supera-CBD has superior potency over plant-derived CBD by factor of 8,000 times
Read More
